Group items tagged

Another case is ready for you: "East Meets West: An Infectious Disease Case" by Harry M. Zollars, Catherine D. Santanello, and Marcelo J. Nieto, Department of Pharmaceutical Sciences, Southern IL University Edwardsville.   Ying is sick and is progressively getting worse. His parents' clashing views on Eastern and Western medicine prevent them from agreeing on a course of treatment. As the case unfolds, students follow the progression of their son's illness. After a physician is finally seen and the results of tests are evident, students should be able to narrow the list of possible etiological agents and suggest a potential treatment. In addition, the students should integrate the different health beliefs into the final treatment as well as the aspects of patient counseling. The case works well as an interrupted case that can be assigned to individual students or student teams. This case is appropriate for graduate courses with a component in health care, therapeutics, medicinal chemistry, medicinal plants, microbiology, epidemiology, or cultural competency. Instructors can choose to focus only on the medical components of the case or incorporate the cultural and ethical aspects, depending on course goals and subject area.

269 page  Curriculum Supplement from NIH 5 lessons  Ideas about the role of evolution in medicine Investigating lactose intolerance and evolution evolutionary processes and patterns inform medicine Using evolution to understand influenza Evaluating evolutionary explanations

Articles on personalized medicine for a socratice discussion

At first glance, the research of Bonnie Bassler and Baldomero "Toto" Olivera might not appear to be medical at all. Dr. Bassler works on marine bacteria that glow in the dark, while Dr. Olivera studies venomous snails that hunt by harpooning fish. Yet their findings show what science has revealed time and again-knowledge that can be used to unlock medical secrets is often hidden in unlikely places. Nature has much to teach us, as long as we know where to look and what to look for. Join us for a four-lecture series as Bonnie and Toto guide us through intriguing slices of the natural world revealing how a deeper understanding of nature and biodiversity informs their research into new medicines.

Bonnie Bassler discovered that bacteria "talk" to each other, using a chemical language that lets them coordinate defense and mount attacks. The find has stunning implications for medicine, industry -- and our understanding of ourselves. Bonnie Bassler studies how bacteria can communicate with one another, through chemical signals, to act as a unit. Her work could pave the way for new, more potent medicine.

8:19 video The Nobel Prize in Physiology or Medicine 2015 goes to William Campbell & Satoshi Ōmura "for their discoveries concerning a novel therapy against infections caused by roundworm parasites" and Youyou Tu "for her discoveries concerning a novel therapy against Malaria".

The UK's leading cancer charity yesterday welcomed work by British scientists who created a breed of genetically modified hens that can produce cancer-fighting medicines in their eggs. The research could slash the cost of producing drugs and potentially save the NHS millions of pounds.

A zebrafish model of a rare genetic disease has revealed an unexpected regulatory pathway for cholesterol absorption and processing. The findings, reported in the Journal of Molecular Medicine, were "quite surprising and have the potential to teach us about the basic physiology of cholesterol management," said Ela Knapik, M.D., associate professor of Medicine and Cell and Developmental Biology.

Research leading to almost every Nobel Prize in Medicine awarded since 1901 was dependent on data from animal models.  This fact dramatically demonstrates the important contribution animal models in biomedical research make to both international and American medical progress. In fact, since 1979, every Nobel Prize in Medicine awarded was dependent on data from animal models with the exception of the 1983 Prize awarded to Dr. Barbara McClintock for her work in plant genetics.

Web activities supporting NIH Supplement on Evolution and Medicine

More than 400 scientists, bioethicists, and historians from 20 countries on 6 continents have gathered this week in Washington, DC, for the Human Gene Editing Summit. The attendees are a veritable who's who of genome editing: Jennifer Doudna of the University of California, Berkeley, Emmanuelle Charpentier of Max Planck Institute for Infection Biology, and Feng Zhang of the Broad Institute of MIT and Harvard-the three discoverers of the CRISPR-Cas9 system's utility in gene editing-plus dozens of other big names in genome science. Cal Tech's David Baltimore along with the heads of the four national societies hosting the meeting (US National Academy of Sciences, US National Academy of Medicine, Chinese Academy of Sciences, and the U.K.'s Royal Society) provided opening remarks on Tuesday (December 1). And as I sat stage right in the NAS auditorium, I noticed the unmistakable rear profile of Harvard Medical School's George Church three rows in front of me. Church was scheduled to speak at a session later that afternoon about the application of CRISPR and other new precision gene editing techniques to the human germline-a hot-button topic since April, when a Chinese group published it had successfully modified the genomes of human embryos, and the National Institutes of Health (NIH) said it would not fund such research. Then in September, the U.S./U.K.-based Hinxton Group, an international consortium of scientists, policy experts, and bioethicists, said it supported the use of genetic editing in human embryos for limited applications in research and medicine.  

Find out how researchers identify genetic diseases and determine possible treatments. short film, genes as medicine click and learn, central dogma scientists at work, the search for a mutated gene central dogma card activity animation, CF mechanism and treatment click and learn. CRISPR-Cas9

or more than a decade scientists have been saying that a genomic revolution will transform medicine, making it possible to scan all of a person's DNA to predict risk and customize medical care. Well, we've got the machines. Where's the revolution? Getting closer, say researchers at Stanford University, who tested the technology on 12 people. But not quite ready for every doctor's office.

Pharmacogenomics holds the promise that drugs might one day be tailored to your genetic makeup. By Mayo Clinic Staff Modern medications save millions of lives a year. Yet any one medication might not work for you, even if it works for other people. Or it might cause severe side effects for you but not for someone else. Your age, lifestyle and health all influence your response to medications. But so do your genes. Scientists are working to match specific gene variations with responses to particular medications.

4:10 video, Is personalized medicine for individual bodies in our future? Possibly -- with the use of stem cells, undifferentiated cells with the power to become any tissue in our bodies. Craig A. Kohn describes the role of these incredible, transforming cells and how scientists are harnessing their medical potential.

Fascinating narrative science that explores the next frontier in medicine and genetics through the very personal prism of the children and families gene therapy has touched. Eight-year-old Corey Haas was nearly blind from a hereditary disorder when his sight was restored through a delicate procedure that made medical history.  Like something from a science fiction novel, doctors carefully introduced viruses bearing healing genes into Corey's eyes-a few days later, Corey could see, his sight restored by gene therapy.

By then, researchers had identified three genetic mutations that can be inherited and, if they are, cause a form of Alzheimer's called early onset because it strikes before age 65 and sometimes far earlier. Since 2004, Hornstein and all five of her siblings have been tested. Hornstein is the only one who doesn't carry PSEN1, one of the mutations.

Dubilier is hardly alone in her plight. A heaping teaspoon of soil or a shot of ocean water may contain as many as one million bacterial species. Many of them are potential gold mines of chemicals and metabolites with medicinal, engineering, and energy applications. But when researchers have tried to culture these microbes in the lab, only a minority of cells form colonies. Clearly, nutrients, a carbon source, and time are usually not enough to coax bacteria isolated from the wild to grow in a laboratory setting. So what's the missing ingredient?

The advent of increasingly powerful and inexpensive DNA sequencing methods is changing many aspects of genetics research. In particular, human genome sequencing is transforming our understanding of many aspects of human biology and medicine. However, we must be careful to remember that genes alone do not determine our futures-environmental factors and chance also play important roles.

The idea of a general, quick and simple blood test for a diverse range of cancers just came closer to reality with news of a new study published in Nature Medicine.